BCR and leukemia: Noteworthy, we found that BCR activation was able to restore the expression of BCL2 to basal levels in isolated CLL cells treated with the mithralog, further supporting the pro-survival role of anti-IgM by antagonizing the pro-apoptotic activity of EC-7072 against leukemia cells (Figure 6D).